Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA
Frank Struyf, Brigitte Colau, Cosette M Wheeler, Paulo Naud, Suzanne Garland, Wim Quint, Song-Nan Chow, Jorge Salmeron, Matti Lehtinen, M Rowena Del Rosario-Raymundo, Jorma Paavonen, Julio C Teixeira, Maria Julieta Germar, Klaus Peters, S Rachel Skinner, Genara Limson, Xavier Castellsague, Willy AJ Poppe, Brian Ramjattan, Terry D Klein Show all
Clinical and Vaccine Immunology | AMER SOC MICROBIOLOGY | Published : 2015
Awarded by NATIONAL CANCER INSTITUTE
This work was supported by GlaxoSmithKline Vaccines (registered as GlaxoSmithKline Biologicals SA).B.C., M.-P.D., G.D., and F.S. are employees of the GlaxoSmithKline group of companies (GSK). B.C., M.-P.D., G.D., and F.S. own stock options/restricted shares of GSK. G.D. and B.C. hold patents in the HPV and the herpes simplex virus vaccine fields. X.C., S.G., M.L., P.N., J.S., S.R.S., J.C.T., and C.M.W. declare that their institutions received grants to carry out HPV clinical studies from GSK, Sanofi Pasteur MSD, or Merck & Co. X.C. received personal fees from Sanofi Pasteur MSD. A.C. served on the Speakers Bureau and Advisory Boards for GSK and Merck and received honoraria and travel expenses for related meetings. S.G. received personal fees from GSK as a consultant for EXCEL and received consulting fees from Sanofi Pasteur and Merck. A.M. declares that his company received payments from GSK for HPV testing laboratory services and for consultancy work for GSK related to clinical and epidemiological studies. M.R.D.R.-R. declares that she received fees from GSK for her participation in the Speakers Bureau and for travel to an investigator's meeting. J.S. declares that he received grants from Qiagen. T.F.S. declares that he received personal fees from GSK. S.R.S. declares that she received support from GSK to attend a scientific congress to present the results of the study and received honoraria for attendance at global advisory boards and educational forums; her institution received a grant from CSL to conduct an investigator-driven research project. J.C.T. declares that he received personal fees from GSK for his participation in lectures, the Speakers Bureau, and Advisory Boards. W.A.A.T. declares that he received support for travel for the study and other purposes from GSK and Sanofi Pasteur. C.M.W. declares that she received support from Roche Molecular Systems for equipment and reagents for HPV genotyping studies. S.-N.C., F.D.M., M.J.G., D.M.H., T.D.K, D.J.M.L., G.L., J.P., K.P., W.A.J.P., W.Q., B.R., and L.-J.V.D. declare that they have no conflicts of interest.